LVTX
LAVA Therapeutics NV · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website lavatherapeutics.com
- Employees(FY) 69
- ISIN NL0015000AG6
Performance
-15.11%
1W
-8.65%
1M
+22.22%
3M
+78.38%
6M
+67.09%
YTD
+40.43%
1Y
Profile
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-051, which is in Phase 1/2a clinical trial for blood cancers, including chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia; and LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is also developing other Gammabody drug candidates, which include LAVA-1223, which targets the epidermal growth factor receptor (EGFR) for the treatment of selected solid tumors, as well as LAVA-1266 and LAVA-1278, which are preclinical candidates for the treatment of various hematologic malignancies. LAVA Therapeutics N.V. has a research collaboration and license agreement with Janssen Biotech, Inc. for the potential discovery and development of multi-specific antibody products that are directed to a specified target in various fields of use; and a collaboration with Merck & Co., Inc. to evaluate anti-PD-1 therapy KEYTRUDA in combination with LAVA-1207. The company was incorporated in 2016 and is headquartered in Utrecht, the Netherlands.
Technical Analysis of LVTX 2024-05-10
Overview:
In analyzing the technical indicators for LVTX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2022-09-13 04:05
- 2022-09-06 19:41
- 2022-06-16 04:05
- 2022-06-14 19:00
- 2022-06-01 19:00
- 2022-05-31 19:00
- 2022-05-31 04:05
LAVA Therapeutics Announces Annual Meeting of Shareholders(Yahoo Finance)
- 2022-05-16 19:00
- 2022-05-11 19:00
- 2022-05-05 03:44
- 2022-05-04 19:00
- 2022-04-26 22:05
- 2022-03-23 18:30
- 2022-03-22 05:20
- 2022-03-09 17:30
- 2022-03-06 19:35
- 2022-01-31 17:30
- 2022-01-27 18:00
- 2022-01-17 19:30
- 2021-12-19 21:06
- 2021-12-19 18:00
- 2021-11-14 18:00
- 2021-11-10 23:16
- 2021-11-10 21:08
- 2021-11-08 17:30
- 2021-11-03 19:00
- 2021-11-01 19:00
- 2021-10-14 19:00
- 2021-10-07 00:36
- 2021-10-06 23:31